immunogen inc (IMGN:NASDAQ GS)
Earnings & Estimates Summary - IMMUNOGEN INC (IMGN)
2012 revenues at ImmunoGen, Inc. totaled $16.4M USD, while annual losses equaled $0.95 per share.
Quarterly Earnings & Estimates - IMMUNOGEN INC (IMGN)







ImmunoGen, Inc.'s Quarterly Earnings
ImmunoGen, Inc. reported 3rd quarter 2013 losses of $0.02 per share on 04/28/2013.
Annual Earnings & Estimates - IMMUNOGEN INC (IMGN)




ImmunoGen, Inc.'s Annual Earnings
ImmunoGen, Inc. reported annual 2012 losses of $0.95 per share on 08/5/2012.
Quarterly Revenues - IMMUNOGEN INC (IMGN)







ImmunoGen, Inc.'s Quarterly Revenues
ImmunoGen, Inc. had 3rd quarter 2013 revenues of $25.0M USD. This bettered the $13.4M USD consensus of the 11 analysts covering the company. This was 668.8% above the prior year's 3rd quarter results.
Annual Revenues - IMMUNOGEN INC (IMGN)




ImmunoGen, Inc.'s Annual Revenues
ImmunoGen, Inc. had revenues for the full year 2012 of $16.4M USD. This was -15.3% below the prior year's results.
| Recently Viewed | |||
| IMGN:US | $17.43 USD | +0.40 | |
| Company | Last | Change |
| Bristol-Myers Squibb Co | $46.77 USD | +0.37 |
| Emergent Biosolutions Inc | $14.23 USD | -0.02 |
| Pfizer Inc | $29.12 USD | -0.18 |
| Roche Holding AG | SFr.250.70 CHF | -7.80 |
| Seattle Genetics Inc | $35.00 USD | -0.15 |
| View Industry Companies | ||
Industry Analysis
IMGN
Industry Average
| Valuation | IMGN | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 41.8x |
|
| Price/Book | 10.4x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 36.0x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact IMMUNOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








84.72%